ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARTELO BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 20, 2026
$2.66−0.04 (-1.48%)
Close on Oct 19, 2026
- Market cap
- $7.21M
- P/E (TTM)
- –
- Dividend yield
- –
Artelo Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Market Cap | $1.79M | $166.30M |
| Enterprise Value | -$2.41M | $88.19M |
| PB Ratio | 0.36 | 2.03 |
| P/TBV Ratio | 0.61 | 2.29 |
Income (trailing twelve months)
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Operating Income | -$11.07M | -$21.40M |
| Net Income | -$12.67M | -$22.46M |
| EBITDA | -$11.07M | -$16.91M |
Returns
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -705.7% | -53.2% |
| Return on Assets (ROA) | -234.3% | -40.9% |
| Return on Capital Employed (ROCE) | -221.2% | -38.1% |
Balance sheet
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.20M | $61.43M |
| Net Cash (Debt) | $4.20M | $15.35M |
| Net Cash Per Share | $6.24 | $0.66 |
| Equity (Book Value) | $5.00M | $49.09M |
| Book Value Per Share | $7.42 | $1.37 |
| Tangible Book Value | $2.96M | $23.52M |
| Working Capital | $2.92M | $76.81M |
Financial position
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Current Ratio | 3.00 | 3.34 |
| Quick Ratio | 2.89 | 2.44 |
| Interest Coverage | -48.55 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$12.63M | -$12.35M |
Efficiency
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$2.53M | -$703.34K |
| Employee Count | 5 | 74 |
Dividends and yields
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -707.8% | -23.3% |
| Buyback Yield | -853.5% | -0.59% |
| Shareholder Yield | -853.5% | 0.00% |
Shares
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 673,008 | 58,127,000 |
| Shares Change (YoY) | 329.4% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 289,366 | 49,136,700 |
| Shares Held by Insiders | 57.0% | 11.6% |
Scores
| Measure | Artelo Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | -19.20 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Artelo Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.